Delivery Order SPE2DB24D3013-SPE2DB25FFKHF

Award Date 3/20/25
Potential Completion Date 3/21/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $15,779.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order awarded under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), which is valued at $999,999,999 and runs through November 2026. The contract covers the delivery of Jardiance 25 mg tablets, a medication used for diabetes management, to support...
This federal contract award, valued at $14,528.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $9,872.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of Jardiance 25 mg tablets, a medication used to treat type 2...
This federal contract award, valued at $3,520.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award, valued at $13,158.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to manage diabetes. This is a firm fixed-price delivery order contract with a period of performance through February 2025. The contract is not designated as a set-aside award. In addition to this specific delivery...
This federal contract award, valued at $10,816.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used for the treatment of diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves...
This federal contract award, valued at $8,921.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price delivery order for the supply of Jardiance 10 mg tablets, a medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $16,060.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through...
This federal contract award, valued at $7,538.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to manage diabetes. This is a firm-fixed-price delivery order contract with a completion date of March 20, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award, valued at $12,856.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets over a period ending on January 16, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. It is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFKHF
    Delivery Order

This federal contract award, valued at $10,986.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026.

The contract covers the delivery of Jardiance 25 mg tablets, a medication used for the treatment of diabetes. No set-aside designation was used for this award. Amerisourcebergen, as the prime contractor, will be responsible for supplying this pharmaceutical product to support military healthcare programs and federal medical institutions. The ultimate completion date for this specific delivery order is March 21, 2025.

Generated 6/19/25, 9:45 AM